Parkinsonism & Related Disorders

Article	Citations
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease	139
Error-based biofeedback for gait training in Parkinson's disease	93
Dual Phase 18F-FP-CIT PET in presynaptic and trans-synaptic nigrostriatal dysfunction in Multiple System Atrophy	83
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.	79
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis	78
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care	67
Effect of ND0612 Continuous Infusion on Motor Performance and Experiences of Daily Living in Patients With Parkinson’s Disease	65
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 34	64
FindPD.DaT: Development of a Novel Artificial Intelligence-driven Tool for Diagnosis of Parkinson’s Disease using Dopamine Transporter Scans	47
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.	42
Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson’s Disease using accelerometry	41
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome	40
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder	38
Asymmetric Parkinsonism and Ataxia with autonomic dysfunction and RBD	37
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation	37
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease	36
Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder	36
Diagnosis of vascular parkinsonism: A new tool for gait hypokinesia occurring in older persons	36
Symptom onset lateralization and bilaterality in Parkinson's disease: Clinical implications of motor and non-motor profiles	35
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents	35
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?	33
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia	32
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia	32
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease	30
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS	30

Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors	30
White matter connectivity networks predict early dementia conversion in Parkinson’s disease	30
Chorea-Acanthocytosis: A Case Report	29
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease	29
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease	29
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention	27
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?	26
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.	26
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school	26
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease	26
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease	26
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease	26
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment	26
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease	26
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?	25
The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials	25
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease	25
Psychometric analysis of the short form UCLA Loneliness Scale (ULS-8) in people with Parkinson's disease	25
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study	24
Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration	23
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit	23
Evaluation of mild cognitive impairment in older patients with essential tremor	23
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex	23
Assessment of SLC25A46 variants in idiopathic Parkinson's disease	23
Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin	23
Magnetic resonance spectroscopy reveals evidence of brain oxidative stress in Tourette syndrome	23
Prevalence and clinical impact of alpha-synuclein pathology in idiopathic normal pressure hydrocephalus: Insights from RT-QuIC assay	23
Understanding microlesion and cognitive interactions in STN-DBS: A clinical perspective	23
Impaired sleep microarchitecture is associated with locus coeruleus degeneration in Parkinson's disease	23
Plasma microRNA predict cognitive decline in Parkinson's disease	23
Hemiballistic hemi-myoclonus in Subacute Sclerosing Pan encephalitis – A novel observation	23
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse	22
Machine Learning Analysis of the Interaction Between miR-155 and LRRK2 Gene Variants in Parkinson's Disease Progression	22
Somnolence-Related Events Over Time During Valbenazine Treatment for Chorea Associated with Huntington’s Disease	22
Study of 17β estradiol with neuropeptide and amyloid beta fragment on neuronal and biochemical functions in naturally menopausal aging rats	22
Unveiling the Complexity of Parkinson's Disease: Exploring Subtypes and Tracing its Five-Stage Natural Course	22
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	22
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 2021	22
The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome	22
Clinical Evaluation of Parkinson's Disease Patients Admitted to the Movement Disorders Outpatient Clinic of Istanbul Taksim Training and Research Hospital, Turkey, 2023	22
Huntington Disease – Update on Recent Advances and a Look Toward the Future	22
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China	21
Establishing exercise habits in patients with Parkinson's disease through an exercise group model	21
Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype?	21
The role of neurotrophic factors in development Parkinson's disease dementia	21
Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time	20
Gerstmann-Straussler-Scheinker disease: Lessons from two new Indian kindreds	20
From writer's cramp to blepharoclonus: An atypical journey with a novel KMT2B variant	20
Hereditary Spastic Paraparesis with SPG6 mutation: First case report from Malaysia	20
Motor and non-motor responses of STN DBS in early onset PLA2G6 related Parkinsonism with compound heterozygous mutation from China	20

Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy	20
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism	20
Commentary on “The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials”	20
Dentate calcifications with palatal tremor and facial myorhythmia in adult-onset Cerebral X-linked Adrenoleukodystrophy	20
Atypical Presentation of Autosomal Recessive Cerebellar Ataxia Type I Mimicking Amyotrophic Lateral Sclerosis	20
Genetic overlap between dystonia and other neurologic disorders: A study of 1,100 exomes	19
Functional movement disorders in dopa-responsive dystonia	19
The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study	19
Expert commentary: Teaching points from A young patient with spastic paraparesis and ataxia due to P102L GSS	19
Segmental dystonia as the prominent phenotype resulting from a MICU1 splice variant in a new Indian case	19
Sex differences for cognitive decline in progressive supranuclear palsy	19
A young man with progressive dysarthria, generalized slowness and memory loss	19
Colony-Stimulating Factor-1 Receptor-Related Disorders in the Hispanic Population: A Report of six Families	18
On demand inhaled levodopa in Parkinson´s disease (pd) patients with device assisted therapies	18
The BEACON Study: LRRK2 inhibition by BIIB122/DNL151 in participants with Pathogenic LRRK2 Variants and Parkinson’s disease	18
Effect of Safinamide on Non-motor symptoms and QoL According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose	18
Protective Lifestyle Risk Factors Against Parkinson’s Disease In Sub-Saharan Africa: A Review On Current Evidence	18
Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India	18
Dopaminergic dysfunctions instigated by Nano-formulation of Neonicotinoid pesticides in mice	18
Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease	18
Augmented reality cueing for freezing of gait: Reviewing an emerging therapy	17
A late-onset neurological disorder: Is progression inevitable? Expert Commentary	17
The distinctive functional connectivity of the cholinergic nucleus basalis of Meynert in Parkinson’s disease across different cognitive status	17
Editorial Board	17
¿It Is Any Difference Between Directional Vs Omnidirectional Lead For Treatment In Parkinson Disease?	17
Editorial Board	17
Tardive dyskinesia versus tardive syndrome. What is in a name?	17
Deep learning-based MRI segmentation for substantia nigra in Parkinson's disease with cognitive impairment	17
Editorial Board	17
Cognitive and neuropathological contributions to gait dysfunction in Parkinson's disease	16
Levodopa, homocysteine and Parkinson's disease: What's the problem?	16
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis	16
Brittle dyskinesias after bilateral STN DBS: dissociation of microlesioning effect on tremor versus on dyskinesias	16
A de novo GRIA3 variant with complex hyperkinetic movement disorder in a girl with developmental delay and self-limited epilepsy	16
Genetic study of early-onset Parkinson's disease in the Malaysian population	16
Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy	16
Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks	16
Machine Learning-based World Health Organization Disability Assessment Schedule for persons with Parkinson's disease	16
MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson's disease	16
Frequency settings of subthalamic nucleus DBS for Parkinson's disease: A systematic review and network meta-analysis	15
Impact of inpatient mobility on outcomes in Parkinson's disease	15
The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease	15
Phenotypic manifestations of KIF5A Arg1007Lys mutation: A large kindred study	15
Differences in progressive supranuclear palsy in patients of Asian ancestry?	15
Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective	15
Diagnostic performance of T1-Weighted MRI gray matter biomarkers in Parkinson's disease: A systematic review and meta-analysis	15
Atypical antipsychotic use and mortality risk in Parkinson disease	15
Introducing Virtual Shared Medical Appointments as a Novel Treatment Platform for Functional Movement Disorders	15
Association of bilateral oophorectomy with incidence of Parkinson's disease: A systematic review and meta-analysis	15
Personality assessment with Temperament and Character Inventory in Parkinson's disease	15
Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs	15
Neuropsychological studies in children with tic hyperkinesis	14
Dopaminergic connectivity reconfiguration in the dementia with Lewy bodies continuum	14
Cognitive function, psychobehavioral symptoms, and MRI features in patients with non-demented Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies	14
Mixture effects of dietary fatty acids on Parkinson's disease: A weighted quantile sum analysis	14
Identification of the needs of patients with Parkinson’s disease through a qualitative research process	14
Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) Presenting With Parkinsonism Findings: A Case Report	14
ERCC4 variants causing neurodegeneration with ataxia and chorea in three siblings in Lithuanian family	14
The feasibility of using loss of “swallow tail sign” on 3T – susceptibility weighted MRI in diagnosis of Parkinson’s disease	14
MRgFUS of the nucleus ventralis intermedius in essential tremor modulates functional connectivity within the classical tremor network and beyond	14
Correcting vertical perception to reverse Pisa syndrome in Parkinson's disease: A case report	14
The role of semispinalis capitis muscles in cervical dystonia with goose-neck posture	14
The factors for choosing intesticular gel therapy	14
REM density in Parkinson’s disease: Effects of motor, cognitive, and autonomic function, and the impact of evening dopaminergic medication	14
Ethnoracial differences for caregiving burden in Parkinson’s disease	14
Patients with progressive supranuclear palsy need to be seen sooner and more frequently	14
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	14
Interaction between caffeine intake and polymorphisms of PARK16 modifies Parkinson’s Disease risk	14
Cerebellar blood perfusion is a diagnostic, but not a prognostic, marker for parkinsonian-dominant type multiple system atrophy	13
Thyroid disease in cervical dystonia	13
Improvement of non-motor symptoms with NE3107 adjunctive to Carbidopa / Levodopa in patients with Parkinson`s disease: A Phase 2A, placebo-controlled study	13
Late-onset parkinsonism in a patient with a novel frameshift THAP1 variant	13
Real-world effect of age on long-term effectiveness and safety of levodopa-carbidopa intestinal gel: post hoc analysis from the DUOGLOBE study	13
Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions	13
Spinocerebellar ataxia subtype 40: Report of a case and review of literature	13
Sexual dysfunction in patients with focal dystonia	13
Analysis of GIPC1 CGG repeat expansions in essential tremor	13
Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis	13
Editorial Board	13
Reliability of remote video ratings of the scale for assessment and rating of ataxia	13

Seronegative basal ganglia encephalitis mimicking dementia of Lewy body	13
Cropland associated with risk of Parkinson's disease in the northern Great Plains	13
“A man with an arched back”: Expert commentary	13
The effects of once-daily opicapone 50 mg on the pharmacokinetics of levodopa administered as carbidopa/levodopa extended-release capsules: an open-label study	13
Association between cognitive adverse effects of anticholinergic medication and development of dementia in Parkinson's disease	12
Grey matter correlates of dystonic soft signs in essential tremor	12
The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials	12
Comparative pharmacokinetics of levodopa–carbidopa intestinal gel infusion and foslevodopa–foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's disease	12
Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study	12
Tremor is associated with familial clustering of dystonia	12
Altered subthalamic alpha-beta oscillations in PRKN-associated early onset Parkinson's disease in relation to off-dystonia	12
Reply to: Transcriptomic analysis of plasma small extracellular vesicles identifies potential diagnostic biomarkers for Parkinson's disease dementia	12
Parkinson's disease with and without history of Agent Orange exposure: A prospective study of US Veterans	12
Post-COVID parkinsonism: A scoping review	12
TorsinA-interacting protein 2 (TOR1AIP2) variants in an autosomal dominant combined dystonia-hemichorea-hemiballismus syndrome in two families	11
Development of a screening AI model for Parkinson's disease using gait image sequences	11
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study	11
Usage of modern technologies like VR therapy, physio therapy along with levodopa in Young-Onset Parkinson's disease patients	11
Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson's disease	11
Transcranial high-intensity Magnetic Resonance-guided focused ultrasound (tcMRgFUS) – safety and impacts on tremor severity and quality of life	11
Comment on “Defining ‘OFF’ time in device-aided therapy criteria for Parkinson's disease: Gaps and opportunities”	11
Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease	11
Magnetic Resonance Imaging Marker for the Conversion from Idiopathic Late-onset Cerebellar Ataxia to Multiple System Atrophy	11
The use of botulinum toxin A in the treatment of hand tremor	11
Accelerometric quantification of MDS-UPDRS bradykinesia measurements in PD patients: A pilot study	11
A structural perspective on the interaction between glucocerebrosidase and the positive allosteric modulator BIA 28-6156	11
Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline	11
Tongue strength in progressive supranuclear palsy	11
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)	11
Telomeres, REM sleep, and RBD: A link to neurodegeneration?	11
Empowering the management of early-onset Parkinson’s disease: The role of technology	11
Convergence insufficiency and Parkinson's disease progression	11
Calcium channel blockers and Parkinson's disease: A systematic review and meta-analysis	11
Right to the Point - A Writer’s Cramp Successful Treatment	11
WITHDRAWN	11
Motor band sign in a Huntington disease phenocopy	11
Infrathalamic ablation in advanced Parkinson's disease: Three-year outcomes support a safe and accessible therapeutic strategy	11
Response to levodopa in Parkinson's disease over time. A 4-year follow-up study	11
Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders	11
Recent advances in non-Huntington's disease choreas	11
An atypical case of head tremor	11
Assessment of Cerebral Cortical Atrophy Using Visual Rating Scale in Patients with Functional Movement Disorder	10
Utility of clinical tests for asymmetry in Parkinson's disease and Atypical Parkinsonian disorders: the PARK-SYMM scale study.	10
Real world evidence of efficacy ad safety of subcutaneus foslevodopa/foscarbidopa infusion in advanced Parkinson disease	10
Demonstration of a Prototype Clinical Decision Support System for Diagnosing Parkinson’s Disease	10
Symptom changes with hormonal variations in genetic dystonia	10
Profile of patients with advanced Parkinson’s disease treated with Levodopa–entacapone–carbidopa intestinal gel (LECIG)	10
Enhanced low beta activity in Park2-associated Parkinson’s disease	10
Editorial Board	10
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables	10
Exploring Novel Therapeutic Approaches in Parkinson’s Disease: A Comprehensive Review	10
Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic review	10
Clinical progression of vascular Parkinsonism in ischemic stroke patients with metabolic syndrome	10
Influence of Toxic Exposure on the Age of Onset of Parkinson's Disease: An Observational and Analytical Study.	10
Analysis of interleukin-6 levels in patients with Parkinson's disease by disease stage	10
A benign course of Parkinson's disease associated with different mutations in the glucocerebrosidase gene – A case series	10
A challenging case of cerebellar ataxia associated with oro facial dominant chorea	10
Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases	10
Developing a Female-Specific Mouse Model for Parkinson’s Disease Using a High-Sensitivity Neural Network	10
Efficacy of Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis	10
A novel GNAL pathogenic variant leading to generalized dystonia: Immediate and sustained response to globus pallidus internus deep brain stimulation	10
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome	10
A Novel Missense Mutation in the Spectrin Repeat of SPTBN2 Identified in Spinocerebellar Ataxia Type 5	10
The influence of fatigue on motor imagery ability in people with Parkinson’s disease – preliminary study	10
MOBP gene risk variant is associated with higher cerebrospinal fluid levels of neurofilament light chain: a Barcelona PSP Registry study	10
Challenges during prayer (namaz/salah) rituals in Muslim patients with Parkinson’s disease	10
A multidisciplinary telemedicine approach for managing frailty in Parkinson's disease. A longitudinal, case-control study	9
Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study	9
Functional movement disorder comorbidity in Parkinson's disease: A multicenter descriptive study	9
Utilizing technology-based outcome measures in the natural setting to answer intriguing clinical questions in Parkinson disease	9
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation	9
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease	9
Chorea-acanthocytosis with homozygous variant of VPS13A gene concomitant with intermediate expansion of JPH3 gene: Who is the villain?	9
Structural and functional brain abnormalities in idiopathic cervical dystonia: a multimodal meta-analysis	9
Structural and functional connectomics of the olfactory system in Parkinson's disease: a systematic review	9
Diagnosis across a cohort of “atypical” atypical and complex parkinsonism	9
High preoperative gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation	9
Inter-muscular coherence in speed skaters with skater's cramp	9
An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease	9
Multiple system atrophy like presentation with hot-cross bun sign in anti-IgLON5 disease	9
Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease	9
Non-pharmacological rehabilitation for people living with advanced Parkinson's disease: A scoping review of interventions	9
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel	9
Comparison of voice parameters, self-assessment of speech and sialorrhea levels in Parkinson's disease patients with and without swallowing problems	9
Editorial Board	9
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease	9
Long-term safety of continuous levodopa/carbidopa infusion with ND0612: results from the ongoing BeyoND study	9
Association of subthalamic beta frequency sub-bands to symptom severity in patients with Parkinson's disease: A systematic review	9
Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial	9
Decreased cerebral ATP in pre-motor manifest Huntington's disease: A pilot study	9
Editorial Board	9
Exploring regional BOLD fluctuations to understand the pathophysiology of mild cognitive impairments in individuals with Parkinson's disease	9
Leucine-rich repeat kinase2 (LRRK2) associated Parkinson's disease: less vulnerable during Covid-19 pandemic?	9
Double blind, nonrandomized crossover study of active recharge biphasic deep brain stimulation for primary dystonia	9
Backward leaning during gait: An underrecognized sign in Niemann-Pick type C	9